Review





Similar Products

96
Bio-Techne corporation human/mouse/rat sox2 antibody
Human/Mouse/Rat Sox2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/custom%40af2018%4042382726?v=Bio-Techne+corporation
Average 96 stars, based on 1 article reviews
human/mouse/rat sox2 antibody - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

99
Antibodies Inc anti-sox2 antibody
Anti Sox2 Antibody, supplied by Antibodies Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/custom%40sox2-0100%4042432363?v=Antibodies+Inc
Average 99 stars, based on 1 article reviews
anti-sox2 antibody - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

93
Miltenyi Biotec sox2
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Sox2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pmc13352860-131-60-63?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
sox2 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

86
Servicebio Inc rabbit anti sox2
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Rabbit Anti Sox2, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pm42320254-131-22-27?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
rabbit anti sox2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Jackson Laboratory sox2 creert2 114
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Sox2 Creert2 114, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pm42275232-47-0-2?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
sox2 creert2 114 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc sox2
Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
Sox2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pmc13052523-51-16-26?v=Cell+Signaling+Technology+Inc
Average 96 stars, based on 1 article reviews
sox2 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

86
Novogene sox2 activated lung tumors
Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) <t>and</t> <t>Sox2-activated</t> (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .
Sox2 Activated Lung Tumors, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pmc13198274-569-3-15?v=Novogene
Average 86 stars, based on 1 article reviews
sox2 activated lung tumors - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Musashi Engineering Inc sox2
Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) <t>and</t> <t>Sox2-activated</t> (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .
Sox2, supplied by Musashi Engineering Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pm42151414-180-23-20?v=Musashi+Engineering+Inc
Average 86 stars, based on 1 article reviews
sox2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Jackson Laboratory sox2 flox mice
Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) <t>and</t> <t>Sox2-activated</t> (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .
Sox2 Flox Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/us12618070-575-1-6?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
sox2 flox mice - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Jackson Laboratory sox2 creer mice
Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) <t>and</t> <t>Sox2-activated</t> (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .
Sox2 Creer Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sox2/pm42072344-54-11-14?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
sox2 creer mice - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

Journal: Stem Cell Research & Therapy

Article Title: Activation of the G-protein coupled estrogen receptor 1 (GPER1) reduces transient receptor potential vanilloid 1 (TRPV1) activity and human iPSC-derived nociceptive neuron firing

doi: 10.1186/s13287-026-05174-3

Figure Lengend Snippet: Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

Article Snippet: Subsequently, cells were incubated in inside fix solution of the Inside Stain Kit (#130-090-477, Miltenyi Biotec, Bergisch Gladbach, Germany) for 20 min at RT and centrifuged at 200xg for 5 min. After washing in 500 μl PEB buffer and centrifugation at 200xg cells were stained with the nuclear stem cell markers OCT3/4 (1:50, #130-117-821, Miltenyi Biotec, Bergisch Gladbach, Germany) and SOX2 (1:50, #130-120-790, Miltenyi Biotec, Bergisch Gladbach, Germany) in inside perm solution for 10 min at RT.

Techniques: Virus, Derivative Assay, Staining, Generated, Flow Cytometry, Control, Expressing

Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) and Sox2-activated (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .

Journal: Cell Reports Medicine

Article Title: An autochthonous CRISPR activation screening platform for characterizing tissue-specific oncogene selection

doi: 10.1016/j.xcrm.2026.102759

Figure Lengend Snippet: Sox2 activation accelerates lung tumor initiation and progression (A) Timeline of the Sox2 activation experiment. (B) Representative macroscopic images and corresponding computed tomography (CT) scans of non-targeted (NT) and Sox2-activated (sgSox2) PPKS lungs at 8 weeks. Scale bar, 1 cm. (C) Relative lung weights for NT and sgSox2 mice at 8 weeks ( n = 8 biological replicates/group). (D) CT voxel attenuation for NT and sgSox2 lungs at 8 weeks ( n = 11–12 biological replicates/group). (E) Histology, IHC (dCas9VP64 and Ki-67), and Alcian blue staining of NT and sgSox2 lungs at 8 weeks. Scale bars, 150 μm. (F) Quantification of dCas9VP64+ cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (G) Quantification of Ki-67-positive cells in NT and sgSox2 lungs at 8 weeks ( n = 8 biological replicates/group). (H) Kaplan-Meier survival plot for NT (median survival 144 days) and sgSox2 (median survival 83 days) mice ( n = 6–7 biological replicates). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and log rank (Mantel-Cox) for survival. ∗∗ p < 0.01, ∗∗∗ p < 0.001. Error bars indicate SEM. See also .

Article Snippet: For profiling of Sox2-activated lung tumors, stranded mRNA (polyA-selected) libraries were generated and sequenced by Novogene.

Techniques: Activation Assay, Computed Tomography, Staining, Two Tailed Test

Delineating Sox2-mediated transcriptomic reprogramming (A) Schematic of transcriptomic profiling ( n = 4 biological replicates). (B) Heatmap of all differentially expressed genes at survival endpoint (sgSox2 vs. NT). (C) Expression of Sox2 in Sox2-activated and control tumors ( n = 4 biological replicates). Error bars indicate SEM. (D) IHC of SOX2 in Sox2-activated and control lungs at 8 weeks. Scale bar, 150 μm. (E) Quantification of SOX2 IHC ( n = 4–5 biological replicates). Error bars indicate SEM. (F) Heatmap of LUSC- and LUAD-associated transcripts in Sox2-activated and control tumors. (G) Heatmap of transcripts associated with mucinous cancer and gastric metaplasia in Sox2-activated and control tumors ( n = 4 biological replicates). (H) IHC of NKX2-1, TFF1, and MUC5AC. Scale bar, 150 μm. (I) Quantification of NKX2-1, TFF1, and MUC5AC IHC at 8 weeks and survival endpoint (n = 4–5 biological replicates). EP, survival endpoint. (J) Volcano plot of mucin and gastric metaplasia genes in SOX2-high vs. -low KRAS-mutant human LUAD (TCGA-LUAD KRAS-mutant cohort, n = 89 cases). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and for multiple comparisons using one-way ANOVA with multiple comparisons correction. For differences in gene expression, adjusted p values ( q values) from DEseq2 were used. ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. See also .

Journal: Cell Reports Medicine

Article Title: An autochthonous CRISPR activation screening platform for characterizing tissue-specific oncogene selection

doi: 10.1016/j.xcrm.2026.102759

Figure Lengend Snippet: Delineating Sox2-mediated transcriptomic reprogramming (A) Schematic of transcriptomic profiling ( n = 4 biological replicates). (B) Heatmap of all differentially expressed genes at survival endpoint (sgSox2 vs. NT). (C) Expression of Sox2 in Sox2-activated and control tumors ( n = 4 biological replicates). Error bars indicate SEM. (D) IHC of SOX2 in Sox2-activated and control lungs at 8 weeks. Scale bar, 150 μm. (E) Quantification of SOX2 IHC ( n = 4–5 biological replicates). Error bars indicate SEM. (F) Heatmap of LUSC- and LUAD-associated transcripts in Sox2-activated and control tumors. (G) Heatmap of transcripts associated with mucinous cancer and gastric metaplasia in Sox2-activated and control tumors ( n = 4 biological replicates). (H) IHC of NKX2-1, TFF1, and MUC5AC. Scale bar, 150 μm. (I) Quantification of NKX2-1, TFF1, and MUC5AC IHC at 8 weeks and survival endpoint (n = 4–5 biological replicates). EP, survival endpoint. (J) Volcano plot of mucin and gastric metaplasia genes in SOX2-high vs. -low KRAS-mutant human LUAD (TCGA-LUAD KRAS-mutant cohort, n = 89 cases). Statistical significance for pairwise comparisons using Student’s two-tailed t test for bar graphs and for multiple comparisons using one-way ANOVA with multiple comparisons correction. For differences in gene expression, adjusted p values ( q values) from DEseq2 were used. ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. See also .

Article Snippet: For profiling of Sox2-activated lung tumors, stranded mRNA (polyA-selected) libraries were generated and sequenced by Novogene.

Techniques: Expressing, Control, Mutagenesis, Two Tailed Test, Gene Expression